Results 71 to 80 of about 6,579 (162)

Pharmacokinetic assessment of elexacaftor/tezacaftor/ivacaftor and their metabolites in maternal blood, cord blood, the neonate, and breastmilk of a cystic fibrosis carrier mother/affected fetus dyad. [PDF]

J Cyst Fibros
Sinkey RG, Garcia B, Fowler CM, Krick S, Ryan KJ, Acosta EP, Guimbellot JS.   +6 more
europepmc   +1 more source

PolyA_DB v4: systematic polyA site identification and isoform annotation in human and mouse genomes using 3' end and long-read sequencing data. [PDF]

Nucleic Acids Res
Yu S, Chen WC, Wang L, Jewell S, Mammedova A, Han SW, Wickramasinghe J, Barash Y, Tian B.   +8 more
europepmc   +1 more source

Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR. [PDF]

Sci Prog
Cholon DM, Aleksandrov LA, Quinney NL, Boyles SE, Jensen TJ, Aleksandrov AA, Gentzsch M.   +6 more
europepmc   +1 more source

Dziesięć tez o socjologii

, 2012
The author presents his personal view of sociology formulated in ten theses. The current main threats to sociology are found on the one hand in the anti-scientific claims of postmodernism denying the possibility of social scientific regularities and mechanisms, and on the other hand in the leftist activism turning sociology into ideological and ...
openaire   +1 more source

Metatranscriptomic analyses of gut bacterial and viral communities in the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) under distinct environments. [PDF]

Anim Microbiome
Fan S, Liu H, Yan Y, Xu M, Wan X, Hao Y, Gong C, Wang C, Zhang Y, Liu D, Zheng J, Chen J.   +11 more
europepmc   +1 more source

Mietek Pachter, „Umierać też trzeba umieć”

Zagłada Żydów, 2016
Bartłomiej Krupa
doaj   +1 more source

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR. [PDF]

Front Pharmacol
Pranke I, Capurro V, Chevalier B, Pesce E, Tomati V, Pastorino C, Kelly-Aubert M, Hatton A, Dreano E, Lena M, Bocciardi R, Zara F, Pantano S, Terlizzi V, Lucanto C, Costa S, Claut L, Daccò V, Poli P, Maschio M, Fabrizzi B, Caporelli N, Cipolli M, Volpi S, Chedevergne F, Cosson L, Macey J, Ramel S, Weiss L, Grenet D, Le Clainche-Viala L, Douvry B, Ravoninjatovo B, Audousset C, Tatopoulos A, Richaud-Thiriez B, Baravalle M, Thouvenin G, Labbé G, Mittaine M, Reix P, Durieu I, Mankikian J, Bui S, Nguyen-Khoa T, Khoukh K, Martin C, Da Silva J, De Carli P, Castellani C, Cresta F, Galietta L, Guillemaut A, Girodon E, Remus N, Bulcaen M, Ensinck M, Zajac M, Carlon M, LeBihan J, Burgel PR, Sermet-Gaudelus I, Hinzpeter A, Pedemonte N.   +63 more
europepmc   +1 more source

Effect of a partial loss of function MC3R mutation on MC3R+GHSR-1A heterodimer activity and RNF11 regulation. [PDF]

J Endocrinol Invest
Durhan ST, Yanovski JA, Ozcubukcu S, Yanik T.   +3 more
europepmc   +1 more source

Mesenteric Fibromatosis Presenting As Acute Abdominal Pain Mimicking a Perforated Viscus: A Case Report. [PDF]

Cureus
Kostara K, Tez M, Velazquez B, Liguori T, Kostaras V.   +4 more
europepmc   +1 more source

Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study. [PDF]

Eur Respir J
Mall MA, Wainwright CE, Legg J, Chilvers M, Gartner S, Dittrich AM, Stehling F, Conner S, Grant S, Suresh N, Weinstock TG, Davies JC, VX20-445-119 Study Group.   +12 more
europepmc   +1 more source